1. Home
  2. NGVT vs VERA Comparison

NGVT vs VERA Comparison

Compare NGVT & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingevity Corporation

NGVT

Ingevity Corporation

N/A

Current Price

$69.82

Market Cap

2.4B

Sector

Industrials

ML Signal

N/A

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$29.88

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NGVT
VERA
Founded
1964
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
NGVT
VERA
Price
$69.82
$29.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
14
Target Price
★ $89.00
$77.50
AVG Volume (30 Days)
215.0K
★ 2.4M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.10
N/A
EPS
★ 2.67
N/A
Revenue
★ $1,167,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.74
$792.38
P/E Ratio
$26.75
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$45.85
$23.05
52 Week High
$79.29
$56.05

Technical Indicators

Market Signals
Indicator
NGVT
VERA
Relative Strength Index (RSI) 46.06 38.05
Support Level $68.03 N/A
Resistance Level $70.69 $36.95
Average True Range (ATR) 2.00 1.62
MACD 0.03 -0.32
Stochastic Oscillator 29.23 17.22

Price Performance

Historical Comparison
NGVT
VERA

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: